Mission Therapeutics said Tuesday it raised a 60 million pound ($85.8 million) financing round led by Imperial Innovations Businesses LLP. New investor Woodford Patient Capital Trust Plc took part with follow-on investment from existing shareholders Sofinnova Partners, SR One, Roche Venture Fund and Pfizer Venture Investments. U.K.-based Mission Therapeutics is a drug discovery and development company.
{iframe}https://www.pehub.com/2016/02/660289/{/iframe}